TVM Capital
Venture capitalMunich · Seed–Late Stage · 6 people tracked
Also known as TVM CAPITAL GMBH · TVM Techno Venture Management GmbH
Find your way into TVM Capital
902 people in our graph share verified history with the TVM Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
TVM Capital Life Science pursues a two-pronged investment strategy. First, it finances innovative early-stage therapeutics using a single-asset company approach, leveraging a strategic relationship with Eli Lilly and Company. Second, it invests in differentiated commercial-stage medtech, diagnostics, and digital health products, as well as late-stage therapeutics. The firm aims to develop and market products with the potential to transform medical practice and improve outcomes for patients and the healthcare system, while building value for its investors. It emphasizes strong support for its portfolio companies.
Source: firm website, verified Aug 3, 2026.
Team · 6 people
from the firm's website & curated & public directories
What they invest in
from 4 of 7 portfolio companiesBiotech ×3Healthtech ×2Medical Devices ×2Hardware ×1New Materials ×1
HQs:United States×4
Investments · 7 tracked
founders shown can be your intro pathBy year:2021 · 12017 · 12015 · 13 dated
Access Vascular develops thrombus-evading intravascular catheters made from a proprietary biomaterial, offering an FDA-cleared PICC and the HydroMID peripherally inserted midline catheter to reduce vascular access complications.
BiotechHealthtechMedical DevicesNew MaterialsBedford, US
James Biggins(Chief Executive Officer, President and Founder)inDennis Byrne(Chief Commercial Officer)inScott Blood(VP of Regulatory and Quality)inKatie Motherway(VP of Human Resources)inPaul Sabin(Director)Joseph Pellegrino(Director)
Board seatLuc Marengere· per SEC Form D
Co-investorsTVM Capital Life ScienceGreen Park & Golf Ventures
Egg Medical develops the EggNest, a scatter radiation shielding system designed to reduce radiation exposure for interventional fluoroscopy teams during cardiac catheterization and endovascular procedures.
HardwareHealthtechMedical DevicesArden Hills, US
Robert F. Wilson(Founder & Chief Executive Officer)inJohn Gainor(Co-founder & Chief Technology Officer)inScott Youngstrom(Chief Financial Officer)inGavin Philipps(Chief Commercial Officer)in
BoardMarc Riviere(Director)Luc Marengere(Director)
Co-investorsJStar Capital InvestmentsTVM Capital Life Science
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Acer TherapeuticsCoLucid PharmaceuticalsAcanthasAurka PharmaCoLucid
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 3
3 acquisitionsAcanthasacq. by Eli LillyAurka Pharmaacq. by LillyCoLucidacq. by Lilly
Portfolio news
latest coverage across their companies
Egg Medical · intelligence360.news · Jul 20, 2026
Public market activity · per SEC filings
what is this? ⓘDisclosed stake · filed Mar 2011
Disclosed stake · filed Feb 2008
10 insider ownership filings (Forms 3/4/5)
From the firm's own SEC EDGAR filings — stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.
Frequently asked questions
- How many investments has TVM Capital made?
- TVM Capital has 7 tracked investments, 3 of which have exited.
- What stage does TVM Capital invest at?
- TVM Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is TVM Capital's typical check size?
- TVM Capital typically writes checks of $1.1M – $16.2M.
- What sectors does TVM Capital focus on?
- TVM Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is TVM Capital located?
- TVM Capital is headquartered in Munich, DE.
- Does TVM Capital lead rounds?
- Yes, TVM Capital leads investment rounds.
Media · Podcasts & interviews
featuring the teamBIO-Europe 2025: Interview with Dr. Hubert Birner from TVM Capital Life Science
MC Services AG · Hubert Birner
Bob Wilson, EGG Medical & Luc Marengere, TVM Capital Life Science - Studio Interview | LSI USA ‘24
LSI - Life Science Intelligence™ · Luc Marengere
BIO-Europe Spring 2024: Interview with Hubert Birner from TVM Capital Life Science
MC Services AG · Hubert Birner
BIO-Europe 2023: Interview with Hubert Birner of TVM Capital
MC Services AG · Hubert Birner
Where is the Money Going in Biotech? - Hubert Birner, Managing Partner at TVM Capital
Labiotech.eu · Hubert Birner
Images
Similar investors
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
New Alliance Capital is a Shanghai-based private equity and venture capital firm founded in 2008, focused on technology-driven sectors. Its backers include state-owned enterprise groups, insurance capital, fund-of-funds, government guidance funds, and listed companies.
Bay City Capital is a venture capital firm founded in 1997 that has raised five venture funds totaling $1.3 billion in capital commitments and invested in more than 100 companies worldwide.
Gilde Healthcare is a specialist investment firm managing healthcare and climate-focused funds across venture & growth, and private equity strategies with a transatlantic team of sector specialists.
Clal Biotechnology Industries (TASE: CBI) is an Israeli life sciences investment firm listed on the Tel Aviv Stock Exchange, focused on identifying and developing ventures that create proprietary solutions for unmet medical needs.